We are live on ! Find out more
SASS icon

M.D. Sass Concentrated Value ETF

4 hedge funds and large institutions have $68.2M invested in M.D. Sass Concentrated Value ETF in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding

Funds holding: 1 → 4 (+3)

91.3% less ownership

Funds ownership: 91.3% → 0% (-91%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
4
Holders Change
+3
Holders Change %
+300%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Sellers

No sellers this quarter

SASS Hedge Fund Activity: Q3 2026 in Review

4 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in M.D. Sass Concentrated Value ETF (SASS) for Q3 2026, worth a combined $68.2M — down 5.6% from $72.2M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new SASS positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $635K.

  • 4 institutional investors held M.D. Sass Concentrated Value ETF (SASS) as of Q3 2026, up from 1 in Q2 2026.
  • Funds reported $68.2M of M.D. Sass Concentrated Value ETF stock for Q3 2026, down 5.6% quarter-over-quarter.
  • 3 funds opened new M.D. Sass Concentrated Value ETF positions in Q3 2026 and 0 closed out, a net change of +3 holders.
  • The largest M.D. Sass Concentrated Value ETF buyer in Q3 2026 was JP Morgan Chase, an estimated $635K added.

Based on aggregated 13F filings for Q3 2026.